Corona Updates

Though the Covid-19 pandemic is now slowing down across the country, a new sub-variant of the Omicron variant, which has been responsible for the surge in the virus cases in Singapore recently, has been detected in parts of India. A new…
Read More...

Most patients with COVID-19 who have lingering symptoms at 12 months are likely to still have symptoms at 18 months, new data suggest. The findings are drawn from a large study of 33,281 people in Scotland who tested positive for the…
Read More...

AstraZeneca Plc’s nasal spray vaccine failed to elicit a strong immune response to Covid-19 in an early trial, a blow to the UK drug giant’s ambitions for developing an alternative approach to preventing the disease. The spray vaccine…
Read More...

A new COVID-19 wave appears to be brewing in Europe as cooler weather arrives, with public health experts warning that vaccine fatigue and confusion over types of available vaccines will likely limit booster uptake. Omicron subvariants…
Read More...

In a recent development, researchers created a new medication that can turn the COVID-19 that causes SARS-CoV-2 against itself and stop the deadly virus from infecting people. Researchers claim that a novel medication known as NMT5 is…
Read More...

The World Health Organisation (WHO), revising treatment guidelines for Covid-19, has strongly advised against the use of two antibody drugs – sotrovimab and casirivimab-imdevimab. WHO said that these drugs are likely to be ineffective…
Read More...

Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China. The WHO welcomed the new front in the fight against…
Read More...

भारत बायोटेक की नाक के रास्ते दी जाने वाली कोरोना वैक्सीन को इमरजेंसी इस्तेमाल के लिए डीसीजीआई की मंजूरी मिल गई है। स्वास्थ्य मंत्री डॉ. मनसुख मंडाविया ने इस बात की जानकारी दी। यह भारत की पहली नेजल वैक्सीन होगी। माना जा रहा है कि इससे भारत…
Read More...

China extended its lockdown in districts of western megacity Chengdu and ordered more mass testing there from Sunday as it tries to contain a Covid outbreak. Chengdu’s central Jinjiang district will further intensify lockdowns and extend…
Read More...

Chengdu, one of China’s biggest cities with over 21 million residents, went into a lockdown from Thursday as city authorities announced a four-day nucleic acid testing to contain a rising number of Omicron-driven Covid-19 cases, bringing…
Read More...